Business
SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results
IRVINE, Calif., March 27, 2026--SBC announced its financial results for the full fiscal year 2025 (twelve months ended December 31, 2025)
About this update from Sbc Medical Group Holdings Incorporated
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":3289,"height":395,"url":"https://media.zenfs.com/en/business-wire.com/dc650ad3f59f45ef1c21bec82281a537"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/CiLKOY6zAzB8JCZoKp9fdw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTExNQ--/https://media.zenfs.com/en/business-wire.com/dc650ad3f59f45ef1c21bec82281a537","width":960,"height":115},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/VNZhponhodXnVs5nVuhJSw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0yODg-/https://media.zenfs.com/en/business-wire.com/dc650ad3f59f45ef1c21bec82281a537","width":1200,"height":144}},"lazy":false},{"type":"text","content":"Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year","length":88,"tagName":"p","attribs":{}},{"type":"text","content":"IRVINE, Calif., March 27, 2026--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025).","length":464,"tagName":"p"},{"type":"text","content":"Fourth Quarter 2025 Highlights","length":30,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Total revenues were $40 million, representing an 11% year-over-year decrease.","length":77,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year increase.","length":106,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.14 for the three months ended December 31, 2025, representing 133% year-over-year increase.","length":239,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"EBITDA1, which is calculated by adding depreciation and amortization expense and impairment loss on intangible assets to income from operations was $14 million, representing a 35% year-over-year ...